The current treatments for neurodegenerative diseases are mostly symptomatic without affecting the underlying cause of disease. Emerging evidence supports a potential role for immunotherapy in the management of disease progression. Numerous reports raise the exciting prospect that either the immune system or its derivative components could be harnessed to fight the misfolded and aggregated proteins that accumulate in several neurodegenerative diseases. Passive and active vaccinations using monoclonal antibodies and specific antigens that induce adaptive immune responses are currently under evaluation for their potential use in the development of immunotherapies. In this review, we aim to shed light on prominent immunotherapeutic strategies being developed to fight neuroinflammation-induced neurodegeneration, with a focus on innovative immunotherapies such as vaccination therapy.

Introduction: Periodontitis is a severe oral infection that can contribute to systemic inflammation. A large body of evidence suggests a role for systemic inflammation in the initiation of neurodegenerative disease. This systematic review synthesized data from observational studies to investigate the association between periodontitis and neuroinflammation in adults. Methods and materials: A systematic literature search of PubMed, Web of Science, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) was performed for studies published from the date of inception up to September 2021. Search terms for the exposure “oral disease” and outcome “dementia”, “neuroinflammation” and “cognitive decline” were used. Study selection and data extraction were independently undertaken by two reviewers. The final eligible articles were included only if the exposure is periodontitis and the outcome is cognitive impairment or dementia or a topic related to this condition, and if the study was conducted in an adult population. The quality and risk of bias were assessed by Newcastle Ottawa Scale (NOS). Qualitative synthesis was used to narratively synthesize the results. Six cohort studies, three cross-sectional studies, and two case-control studies met the inclusion criteria. These eleven studies were only narratively synthesized. Meta-analysis was not performed due to the methodological heterogeneity of the studies. Results: The results of included studies show that chronic periodontitis patients with at least eight years of exposure are at higher risk of developing cognitive decline and dementia. Oral health measures such as gingival inflammation, attachment loss, probing depth, bleeding on probing, and alveolar bone loss are associated with cognitive impairment. The reduction of epidermal growth factor (EGF), interleukin 8 (IL-8), interferon γ-induced protein 10 (IP-10), and monocyte chemoattractant protein-1 (MCP-1) in addition to over expression of interleukin 1-β (IL-1β) are significant in patients suffering from cognitive decline with pre-existing severe periodontitis. Conclusions: All the included studies show evidence of an association between periodontitis and cognitive impairment or dementia and Alzheimer’s disease pathology. Nonetheless, the mechanisms responsible for the association between periodontitis and dementia are still unclear and warrant further investigation.

Physical exercise has been widely recognized for its positive effects on health and well-being. Recently, the impact of exercise on the nervous system has gained attention, with evidence indicating improvements in attention, memory, neurogenesis, and the release of "happiness hormones." One potential mediator of these benefits is Irisin, a myokine induced by exercise that can cross the blood-brain barrier, reduce neuroinflammation, and counteract neurodegeneration. The objective of this study is to conduct a systematic review of animal trials to summarize the neuroprotective effects of Irisin injection in mitigating neuroinflammation and neurodegeneration. Two independent reviewers screened three databases (PubMed, Embase, and Google Scholar) in November 2022. Animal studies assessing the neuroprotective effects of Irisin in mitigating neuroinflammation or counteracting neurodegeneration were included. The methodological quality of the included studies was assessed using SYRCLE's Risk of Bias tool. Twelve studies met the inclusion criteria. Irisin injection in rodents significantly reduced neuroinflammation, cytokine cascades, and neurodegeneration. It also protected neurons from damage and apoptosis, reduced oxidative stress, blood-brain barrier disruption, and neurobehavioral deficits following disease or injury. Various mechanisms were suggested to be responsible for these neuroprotective effects. Most of the included studies presented a low risk of bias based on SYRCLE's Risk of Bias tool. Irisin injection demonstrated the potential to alleviate neuroinflammation and counteract neurodegeneration in rodent models through multiple pathways. However, further research is needed to fully understand its mechanism of action and its potential applications in clinical practice and drug discovery.

Pharmaceutical personal care products (PPCPs) have increased in consumption due to the worldwide post-pandemic situation, marking them as chemical and pathogenic pollutants in significantly higher concentrations than ever in the ecosystem. Considering the inexplicable levels of these chemical residues discharged into the environment, concerns have been raised regarding their probable ecotoxicity to marine and terrestrial life. A further concern is the potential for developing and spreading antibiotic-resistant microorganisms and genes in aquatic ecosystems due to antibiotic exposure. Hence, knowing how these compounds impact aquatic ecosystem functioning is imperative, and thus is a critical area of research. The ecological risk analysis of PPCPs in aquatic ecosystems has been carried out using various strategies. Previous studies have reported numerous approaches for eliminating these PPCPs, including conventional treatment methods, activated sludge processes, generated wetlands, biological remediation, sequencing batch reactors, phytoremediation, and membrane bioreactors. In terms of green biotechnology approaches, the current research aims to discover effective procedures for removing PPCPs and their emerging resources as pollutants. Therefore, this review focuses on the over-extensive utilization of PPCPs and their emergent sources responsible for the contamination and environmental threat for future wastewater purposes. Further, as fungi and their enzymes and derivatives can remove pharmaceuticals and personal care products from wastewater through oxidation and several processes, they have attracted the attention of the scientific community due to their ability to remove PPCPs as pollutants and their status as emerging resources in wastewater. This review examines the fundamental approach and progress of the bioremediation of pharmaceutical- and personal-care-contaminated wastewater using fungal-based systems. It also discusses mechanistic approaches through hybridizing cultures and other biological systems with fungal strains, current technologies, and prospects for future research on PPCPs in wastewater treatment.

Introduction: Stroke continues to be a common and debilitating medical condition which has a significant effect on public health as the second primary source of mortality and the third major root of disability worldwide. A wide range of complications affecting the survivor's life and interfering with the recovery process usually follows stroke; anxiety and depression are considered one of the major complications post-stroke. This study sought to investigate the short-term psychological consequences of stroke among Lebanese survivors and to identify their correlates.Methods: This study is a prospective observational epidemiological study. 143 stroke patients admitted to hospitals in Mount Lebanon and Beirut between February and May 2018.were included in this study. Assessments of complications were carried out at 3 months post-stroke by completing a 30-min face-to-face interview questionnaire. The survey included the socio-demographic -characteristics of the patients, their lifestyle, health indicators, the severity of stroke, and the post-stroke consequences disturbing their quality of life.Results: Complications were recorded for 117 stroke survivors (mean age, 72.46 years; 60.7% male). The analysis of results 3 months post stroke showed that 29 survivors suffered from neuropathic pain (24.8%), 110 (94%) suffered from fatigue, and 81 (69.2%) from cognitive impairment. High rates of anxiety (51.3%), and depression (76.1%) were recorded as well. Multivariate logistic regression confirmed that there is a significant association between depression and the following variables: anxiety (OR = 4.814, p-value = 0.017), pain (OR = 6.868, p-value = 0.002), and physical activity, which acts as a protective factor against depression (OR = 0.261; p-value = 0.029). However, the results of the multivariate logistic regression analysis for anxiety indicated that immobility-related complications increase the risk of anxiety by 8.457 in sedentary duration longer than 12 h (ORa = 8.457, p-value = 0.01). Furthermore, patients with neuropathic pain (24.8%) are 3.858 times more likely to have anxiety compared to patients without neuropathic pain (ORa = 3.858, p-value = 0.019).Conclusion: Using a patient-centered structure more interventions should take place to evaluate stroke survivors' outcomes, and organize rehabilitation services that deal with stroke consequences, particularly high anxiety and depression levels, which are prevalent and persistent among the Lebanese stroke survivors.

Surgical Site Infections (SSIs) are a significant global health concern, especially after noticing the development of bacteria that are also resistant to several antibiotics. In Lebanon, data on SSIs and their associated antimicrobial resistance patterns are scarce, highlighting a critical gap in local epidemiological knowledge. This study aimed to determine the distribution of bacterial pathogens and evaluate their antibiotic susceptibility among patients with SSIs in various Lebanese hospitals. The research is a multi-center and prospective cross-sectional study in which data was obtained from patients who developed SSIs after surgical procedures within the period of January – September 2024. Swabs from wounds or tissue samples were taken from the patients, while the isolation and identification of bacteria was performed using standard microbiological techniques through culture on media and biochemical identification tests. The antimicrobial resistance profiles were performed using disk diffusion method. Sociodemographic and medical data was collected in the patients’ records. The Data was analyzed using SPSS. In total, 6933 patients were admitted in the surgical departments of different hospitals. SSIs occurred in 63 patients, with a rate of 0.91%, 95% CI [0.70%, 1.15%]. Gram-negative bacteria predominated (46 (73%)) including E. coli (13(20.6%)) and Pseudomonas aeruginosa (12 (19%)), compared to Gram-positive bacteria (17 (27%)) such as Staphylococcus aureus (8(12.7%)). High levels of antibiotic resistance were found in Gram-positive isolates (71%) and Gram-negative isolates (61%), indicating a significant presence of multidrug-resistant organisms which is a serious threat to public health. This study highlights the high prevalence of antibiotic-resistance in bacteria causing SSIs in Lebanese hospitals and underscores the urgent need for stringent infection control and improved antibiotic management.